| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4930750 | European Neuropsychopharmacology | 2017 | 15 Pages |
Abstract
To manage agitation in adults with progressive dementia, clinicians may recommend atypical antipsychotics with continuous monitoring of behavioral symptoms, informing patients and their families or caregivers of the significant risk of adverse effects and baseline risk of acute myocardial infraction and bone fractures.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Martin R. Farlow, Tatyana A. Shamliyan,